Incline Global Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-362,764
Closed -$13.8M 29
2016
Q2
$13.8M Sell
362,764
-273,431
-43% -$12M 3.22% 14
2016
Q1
$26.2M Buy
636,195
+120,776
+23% +$4.98M 6.05% 9
2015
Q4
$25M Sell
515,419
-13,254
-3% -$590K 5.12% 11
2015
Q3
$21.1M Buy
528,673
+433,804
+457% +$18.9M 4.67% 11
2015
Q2
$3.81M Sell
94,869
-135,740
-59% -$4.68M 0.84% 25
2015
Q1
$7.55M Buy
+230,609
New +$6.37M 1.88% 23

Other funds holding SYNH

Incline Global Management's SYNH Position: Q3 2016 in Review

Incline Global Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2016, closing a stake of 362,764 shares — an estimated $13.8M sold.

Incline Global Management first reported a position in SYNH in Q1 2015 and held it in 6 quarters. The position peaked at $26.2M in Q1 2016. 237 funds tracked by Wall St. Rank hold SYNH as of Q3 2016.

  • Incline Global Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2016 after selling out during the quarter.
  • Incline Global Management sold 362,764 Syneos Health, Inc. Class A Common Stock shares in Q3 2016, an estimated $13.8M.
  • Incline Global Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 6 quarters.
  • Incline Global Management's Syneos Health, Inc. Class A Common Stock position peaked at $26.2M in Q1 2016.
  • 237 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2016.

Based on Incline Global Management's 13F filing for Q3 2016, filed 14 Nov 2016.